The association between relevant co-morbidities and prevalent as well as incident heart failure in patients with atrial fibrillation

被引:21
|
作者
Wandell, Per [1 ]
Carlsson, Axel C. [1 ,2 ]
Holzmann, Martin J. [3 ,4 ]
Arnlov, Johan [1 ,2 ,5 ]
Sundquist, Jan [6 ,7 ]
Sundquist, Kristina [6 ,7 ]
机构
[1] Karolinska Inst, Div Family Med & Primary Care, Dept Neurobiol Care Sci & Soc, Huddinge, Sweden
[2] Uppsala Univ, Cardiovasc Epidemiol, Dept Med Sci, Uppsala, Sweden
[3] Karolinska Univ Hosp, Funct Area Emergency Med, Stockholm, Sweden
[4] Karolinska Inst, Dept Internal Med, Stockholm, Sweden
[5] Dalarna Univ, Sch Hlth & Social Studies, Falun, Sweden
[6] Lund Univ, Ctr Primacy Hlth Care Res, Malmo, Sweden
[7] Icahn Sch Med Mt Sinai, Dept Populat Hlth Sci & Policy, Dept Family Med & Community Hlth, New York, NY 10029 USA
基金
瑞典研究理事会; 美国国家卫生研究院;
关键词
Atrial fibrillation; Congestive heart failure; Gender; Hypertension; INDEPENDENT RISK-FACTOR; EJECTION FRACTION; SLEEP-APNEA; TRENDS; STROKE; OUTCOMES; SWEDEN; COHORT; DEATH;
D O I
10.1016/j.jjcc.2017.12.010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Congestive heart failure (CHF) is a serious complication in patients with atrial fibrillation (AF). Objective: To study associations between relevant co-morbidities and CHF in patients with AF. Methods: Study population included all adults (n = 12,283) >= 45 years diagnosed with AF at 75 primary care centers in Sweden 2001-2007. Logistic regression was used to calculate odds ratios with 95% confidence intervals (Cls) for the associations between co-morbidities, and prevalent CHF. In a subsample (n = 9424), (excluding patients with earlier CHF), Cox regression was used to estimate hazard ratios with 95% as for the association between co-morbidities, and a first hospital diagnosis of CHF, after adjustment for age and socio-economic factors. Results: During 5.4 years' follow-up (standard deviation 2.5), 2259 patients (24.0%; 1135 men, 21.8%, and 1124 women, 26.7%) were diagnosed with CHF. Patients with hypertension were less likely to have CHF, while a diagnosis of coronary heart disease, valvular heart disease, diabetes, or chronic obstructive pulmonary disease (COPD), was consistently associated with CHF among men and women. CHF was more common among women with depression. The relative fully adjusted risk of incident CHF was increased for the following diseases in men with AF: valvular heart disease, cardiomyopathy, and diabetes; and for the following diseases in women: valvular heart disease, diabetes, obesity, and COPD. The corresponding risk was decreased among women for hypertension. Conclusions: In this clinical setting we found hypertension to be associated with a decreased risk of CHF among women; valvular heart disease and diabetes to be associated with an increased risk of CHF in both sexes; and cardiomyopathy to be associated with an increased risk of CHF among men. (C) 2018 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:26 / 32
页数:7
相关论文
共 50 条
  • [11] Clinical and prognostic association of total atrial conduction time in patients with heart failure: a report from Studies Investigating Co-morbidities Aggravating Heart Failure
    Nuzzi, Vincenzo
    Pellicori, Pierpaolo
    Nikolaidou, Theodora
    Kallvikbacka-Bennett, Anna
    Torromeo, Concetta
    Barilla', Francesco
    Salekin, Damien
    Kaur, Kuldeep
    Monzo, Luca
    Cleland, John G. F.
    Clark, Andrew L.
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2019, 20 (07) : 442 - 449
  • [12] Co-morbidities in patients with heart failure: an analysis of the European Heart Failure Pilot Survey
    van Deursen, Vincent M.
    Urso, Renato
    Laroche, Cecile
    Damman, Kevin
    Dahlstrom, Ulf
    Tavazzi, Luigi
    Maggioni, Aldo P.
    Voors, Adriaan A.
    EUROPEAN JOURNAL OF HEART FAILURE, 2014, 16 (01) : 103 - 111
  • [13] Effect of co-morbidities on anticoagulation rates among chronic atrial fibrillation patients
    Hernandez, MT
    Harper, CV
    Redberg, RF
    CIRCULATION, 2001, 103 (09) : 1360 - 1360
  • [14] Relationships between Co-Morbidities, Reimbursement and Cost in the Treatment of Heart Failure
    Dunn, Patrick J.
    JOURNAL OF CARDIAC FAILURE, 2009, 15 (06) : S81 - S81
  • [15] Healthcare utilisation, co-morbidities and polypharmacy in community heart failure patients
    Gallagher, J.
    Mulqueen, J.
    Connell, L. O.
    Connell, E. O.
    Ledwidge, M.
    Mcdonald, K.
    Murphy, A.
    Glynn, L.
    EUROPEAN JOURNAL OF HEART FAILURE, 2013, 12 : S173 - S173
  • [16] Association of Co-morbidities with Functional Outcomes in Stroke Patients with Atrial Fibrillation on long-term Oral anticoagulation
    Ayub, Muhammad
    Ansari, Junaid
    Sheikh, Mohammad
    Elsekaily, Omar
    Buchhanolla, Prabandh
    Neshatfar, Amir
    Chappidi, Maithreyi
    Parvathaneni, Arvin
    Triay, Rachel
    Gaudet, Alexandra
    Abushehab, Nimer
    Cuellar-Saenz, Hugo
    Kelley, Roger
    Javalkar, Vijayakumar
    NEUROLOGY, 2023, 100 (17)
  • [17] Co-morbidities in long term prognosis in patients with acute heart failure
    Nagorni, S. Petrovic
    Zdravkovic, S. Ciric
    Stanojevic, D.
    Tomasevic, R. Jankovic
    Atanaskovic, V.
    Topic, V.
    Pavlovic, M.
    Todorovic, L.
    EUROPEAN HEART JOURNAL, 2013, 34 : 297 - 297
  • [18] The impact of psychiatric co-morbidities on the length of stay in patients with heart failure
    Carter, P. R.
    Reynolds, J.
    Carter, A. J.
    Uppal, H.
    Chandran, S.
    Potluri, R.
    EUROPEAN HEART JOURNAL, 2016, 37 : 1321 - 1321
  • [19] Associations between relevant cardiovascular pharmacotherapies and incident heart failure in patients with atrial fibrillation: a cohort study in primary care
    Wandell, Per
    Carlsson, Axel C.
    Holzmann, Martin J.
    Arnlov, Johan
    Sundquist, Jan
    Sundquist, Kristina
    JOURNAL OF HYPERTENSION, 2018, 36 (09) : 1929 - 1935
  • [20] Heart failure: focus on co-morbidities, inflammation, and heart rate
    Luescher, Thomas F.
    EUROPEAN HEART JOURNAL, 2015, 36 (11) : 635 - 637